Texas Cancer Institute in Hot Water, Again

The Cancer Prevention and Research Institute of Texas is under investigation following further concerns about the legitimacy of its grant review process.

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, SUSAN ARNOLDThe District Attorney (DA) of Travis County, Texas, is investigating the Cancer Prevention and Research Institute of Texas (CPRIT) in Austin for possible criminal activity surrounding a recent round of grants it dished out, Nature reported. Concerns seem to revolve around awards given to companies owned by Dallas businessman David Shanahan, who was a major campaign contributor to both Texas governor Rick Perry and Lieutenant Governor David Dewhurst, “who control many of the levers when state dollars are handed out for economic development programs,” The Dallas Morning News reported. Though Shanahan claimed that his campaign contributions—$20,000 to Dewhurst and $15,000 to Perry since 2007—had “no impact of which I am aware” on the public dollars his companies received, his awards from CPRIT came despite receiving low scores from grant reviewers there, raising questions about the politics of CPRIT’s funding mechanism.

By awarding more money to Texas companies, as opposed to university researchers, “there is much more of a chance, using this mechanism, for favoritism to be given, and for politics to be inserted into the process,” J. Wade Harper, a Harvard Medical School professor, told The Dallas Morning News. Citing concerns over the integrity of its peer-review process, Harper recently resigned from CPRIT’s team of reviews—along with many of the rest of the 100 researchers that made up the agency’s expert roster, as well as its entire 8-member scientific review council. These resignations followed those of Nobel Laureate Alfred Gilman, who had served as CPRIT’s chief scientific officer, and another Nobel Prize-winner, Phillip Sharp of the Massachusetts Institute of Technology, former chair of the review ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies